BVXV
Biondvax Pharmaceuticals Ltd
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
biondvax (nasdaq: bvxv) is an innovative biopharmaceutical company developing a universal flu vaccine, designed to provide multi-season and multi-strain protection against most human influenza virus strains, including both seasonal and pandemic flu strains. biondvax’s technology utilizes a unique, proprietary combination of conserved epitopes from influenza virus proteins to activate the immune system for a cross-protecting and long-lasting effect.
Market Cap: 856 Thousand
Primary Exchange: NASDAQ
Website: http://www.biondvax.com
Shares Outstanding: 654 Thousand
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.4212801205671815
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Ethical Flags
Longest drawdown: 1040 trading days
From: 2020-07-13 To: 2023-09-06
Lowest Point:
BiondVax sets terms for rights offering
via: SeekingAlpha at 2019-06-10 04:52:40:000
BiondVax Pharmaceuticals (NASDAQ: BVXV ) announces a rights offering to holders of the Company's American Depositary Shares ("ADSs"). One ADS right entitles to subscribe for and purchase one new ADS. More news on: BiondVax Pharmaceuticals Ltd., Healthcare stocks news, Read more … read more...
BiondVax sets terms for rights offering
via: SeekingAlpha at 2019-06-10 04:52:40:000
BiondVax Pharmaceuticals (NASDAQ: BVXV ) announces a rights offering to holders of the Company's American Depositary Shares ("ADSs"). One ADS right entitles to subscribe for and purchase one new ADS. More news on: BiondVax Pharmaceuticals Ltd., Healthcare stocks news, Read more … read more...
BiondVax sets terms for rights offering
via: SeekingAlpha at 2019-06-10 04:52:40:000
BiondVax Pharmaceuticals (NASDAQ: BVXV ) announces a rights offering to holders of the Company's American Depositary Shares ("ADSs"). One ADS right entitles to subscribe for and purchase one new ADS. More news on: BiondVax Pharmaceuticals Ltd., Healthcare stocks news, Read more … read more...
BiondVax Announces Rights Offering in Support of Ongoing Pivotal, Clinical Efficacy Phase 3 Trial of the M-001 Universal Flu Vaccine and Scale Up of Manufacturing Process
via: PR Newswire at 2019-06-10 04:18:00:000
JERUSALEM, Israel , June 10, 2019 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a clinical stage biopharmaceutical company focused on developing and commercializing M-001, a universal flu vaccine candidate, today announced a rights offering to holders of the Company's Amer… read more...
BiondVax Announces Rights Offering in Support of Ongoing Pivotal, Clinical Efficacy Phase 3 Trial of the M-001 Universal Flu Vaccine and Scale Up of Manufacturing Process
via: PR Newswire at 2019-06-10 04:18:00:000
JERUSALEM, Israel , June 10, 2019 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a clinical stage biopharmaceutical company focused on developing and commercializing M-001, a universal flu vaccine candidate, today announced a rights offering to holders of the Company's Amer… read more...
BiondVax Announces Rights Offering in Support of Ongoing Pivotal, Clinical Efficacy Phase 3 Trial of the M-001 Universal Flu Vaccine and Scale Up of Manufacturing Process
via: PR Newswire at 2019-06-10 04:18:00:000
JERUSALEM, Israel , June 10, 2019 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a clinical stage biopharmaceutical company focused on developing and commercializing M-001, a universal flu vaccine candidate, today announced a rights offering to holders of the Company's Amer… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|